| Dr Carlos N Montalvo, MD | |
|
50 Calle Arrecife, Dorado, PR 00646 | |
| (315) 395-2913 | |
| Not Available |
| Full Name | Dr Carlos N Montalvo |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Location | 50 Calle Arrecife, Dorado, Puerto Rico |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780941468 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | ME 126958 (Florida) | Primary |
| Entity Name | Arecibo Healthcare Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144323395 PECOS PAC ID: 6901822386 Enrollment ID: O20051017000084 |
News Archive
The youngest children in any class at school are, on average, at a 40% higher risk of being diagnosed with Attention Deficit Hyperactivity Disorder (ADHD), and a 30% increased risk of depression or intellectual disability compared to the oldest, says a new study published on September 23, 2019 in JAMA Pediatrics.
Significant disparities exist in diagnosing and treating headaches by race, socioeconomic level, and insurance status, despite the fact that headaches afflict nearly all racial and ethnic groups at the same rate, according to research led by UT Southwestern Medical Center faculty.
The Association of Community Cancer Centers announced that results of a landmark study of how—and how well—the cancer patient's transition from the hospital inpatient setting to outpatient oncology group is managed. The study, designed to help hospitals and oncology groups improve their transition processes. The study was conducted by the Association of Community Cancer Centers, was conducted by ACCC, with strategic research and analysis provided by Health2 Resources.
GlaxoSmithKline has announced the start of an international clinical trial program to test two pandemic vaccines against the H5N1 strain of the avian influenza virus in humans. This dual approach reflects the company's commitment to provide health authorities with concrete options to face the threat of a pandemic.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Carlos N Montalvo, MD 50 Calle Arrecife, Dorado, PR 00646-2007 Ph: (315) 395-2913 | Dr Carlos N Montalvo, MD 50 Calle Arrecife, Dorado, PR 00646 Ph: (315) 395-2913 |
News Archive
The youngest children in any class at school are, on average, at a 40% higher risk of being diagnosed with Attention Deficit Hyperactivity Disorder (ADHD), and a 30% increased risk of depression or intellectual disability compared to the oldest, says a new study published on September 23, 2019 in JAMA Pediatrics.
Significant disparities exist in diagnosing and treating headaches by race, socioeconomic level, and insurance status, despite the fact that headaches afflict nearly all racial and ethnic groups at the same rate, according to research led by UT Southwestern Medical Center faculty.
The Association of Community Cancer Centers announced that results of a landmark study of how—and how well—the cancer patient's transition from the hospital inpatient setting to outpatient oncology group is managed. The study, designed to help hospitals and oncology groups improve their transition processes. The study was conducted by the Association of Community Cancer Centers, was conducted by ACCC, with strategic research and analysis provided by Health2 Resources.
GlaxoSmithKline has announced the start of an international clinical trial program to test two pandemic vaccines against the H5N1 strain of the avian influenza virus in humans. This dual approach reflects the company's commitment to provide health authorities with concrete options to face the threat of a pandemic.
› Verified 5 days ago
Dr. Ricardo D Galan Vazquez, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: Mar Caribe 576 Paseo Los Corales I, Dorado, PR 00646 Phone: 787-278-0522 Fax: 787-278-0522 |